AIMC Topic: Drug Design

Clear Filters Showing 361 to 370 of 582 articles

Deep Learning in Chemistry.

Journal of chemical information and modeling
Machine learning enables computers to address problems by learning from data. Deep learning is a type of machine learning that uses a hierarchical recombination of features to extract pertinent information and then learn the patterns represented in t...

Machine Learning for Molecular Modelling in Drug Design.

Biomolecules
Machine learning (ML) has become a crucial component of early drug discovery. This researcharea has been fueled by two main factors [...].

A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.

Molecules (Basel, Switzerland)
G protein-coupled receptors (GPCRs) play a key role in many cellular signaling mechanisms, and must select among multiple coupling possibilities in a ligand-specific manner in order to carry out a myriad of functions in diverse cellular contexts. Muc...

Pharmacophore features for machine learning in pharmaceutical virtual screening.

Molecular diversity
Methods of three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing. However, some pharmacophore features can be more important in a specific system. In this work, we derived the overlap volume of ph...

Design of Natural-Product-Inspired Multitarget Ligands by Machine Learning.

ChemMedChem
A virtual screening protocol based on machine learning models was used to identify mimetics of the natural product (-)-galantamine. This fully automated approach identified eight compounds with bioactivities on at least one of the macromolecular targ...

The significance of artificial intelligence in drug delivery system design.

Advanced drug delivery reviews
Over the last decade, increasing interest has been attracted towards the application of artificial intelligence (AI) technology for analyzing and interpreting the biological or genetic information, accelerated drug discovery, and identification of th...

Exploiting machine learning for end-to-end drug discovery and development.

Nature materials
A variety of machine learning methods such as naive Bayesian, support vector machines and more recently deep neural networks are demonstrating their utility for drug discovery and development. These leverage the generally bigger datasets created from...

Applications of machine learning in GPCR bioactive ligand discovery.

Current opinion in structural biology
GPCRs constitute the largest druggable family having targets for 475 Food and Drug Administration (FDA) approved drugs. As GPCRs are of great interest to pharmaceutical industry, enormous efforts are being expended to find relevant and potent GPCR li...

Autonomous Molecular Design: Then and Now.

ACS applied materials & interfaces
The success of deep machine learning in processing of large amounts of data, for example, in image or voice recognition and generation, raises the possibilities that these tools can also be applied for solving complex problems in materials science. I...

Automated discovery of GPCR bioactive ligands.

Current opinion in structural biology
While G-protein-coupled receptors (GPCRs) constitute the largest class of membrane proteins, structures and endogenous ligands of a large portion of GPCRs remain unknown. Because of the involvement of GPCRs in various signaling pathways and physiolog...